0000899243-20-004242.txt : 20200212 0000899243-20-004242.hdr.sgml : 20200212 20200212161218 ACCESSION NUMBER: 0000899243-20-004242 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191126 FILED AS OF DATE: 20200212 DATE AS OF CHANGE: 20200212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fikry Christopher CENTRAL INDEX KEY: 0001801814 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39212 FILM NUMBER: 20604195 MAIL ADDRESS: STREET 1: C/O PPD, INC. STREET 2: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PPD, Inc. CENTRAL INDEX KEY: 0001793294 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 453806427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401-3331 BUSINESS PHONE: 910 251 0081 MAIL ADDRESS: STREET 1: 929 NORTH FRONT STREET CITY: WILMINGTON STATE: NC ZIP: 28401-3331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-11-26 0 0001793294 PPD, Inc. PPD 0001801814 Fikry Christopher C/O PPD, INC. 929 NORTH FRONT STREET WILMINGTON NC 28401 0 1 0 0 See Remarks Non-voting common stock 2020-02-10 4 D 0 6645 D 0 D Common stock 2020-02-10 4 A 0 6645 A 6645 D Common stock 2020-02-10 4 P 0 7400 27.00 A 14045 D Stock Options (Right to Buy) 21.70 2019-11-26 4 A 0 40093 0.00 A 2029-11-26 Non-voting common stock 40093 40093 D Upon the completion of the initial public offering of PPD, Inc. (the "Issuer"), all shares of the Issuer's non-voting common stock automatically converted into shares of the Issuer's voting common stock on a one-for-one basis. Shares were acquired in a directed share program in connection with the Issuer's initial public offering. Represents stock options previously granted to the reporting person on November 26, 2019. These stock options were already reflected on the reporting person's previously filed Form 3. Represents 29,032 stock options which are unvested and will vest in equal annual installments on November 26, 2020, November 26, 2021, November 26, 2022, November 26, 2023 and November 26, 2024 and 11,061 unvested stock options which are eligible to vest upon the achievement of certain return on capital or rate of return conditions three years after the initial public offering of the Issuer or earlier, upon certain sales by significant stockholders. Does not include an additional 29,032 stock options with an exercise price of $21.70 which are eligible to vest upon the achievement of certain EBITDA-based vesting conditions for fiscal years 2020-2024. Title: EVP, Global Laboratory Services /s/ B. Judd Hartman, as Attorney-in-Fact 2020-02-12